{
  "id": 16592876,
  "title": "Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial",
  "url": "https://urgent.news/2026/10/26/genmab-soars-as-cancer-drug-impresses-in-a-late-stage-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T10:01:05.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/articles/2026-10-26/genmab-soars-as-cancer-drug-impresses-in-a-late-stage-trial"
  },
  "original_language": "en",
  "account": null,
  "summary": "Genmab A/S shares surged the most in more than six years after its experimental ovarian cancer treatment exceeded analyst expectations in a late-stage trial, boosting confidence in the Danish drugmaker’s pipeline.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}